Dishman Pharmaceuticals & Chemicals: Updates | Value Research

Dishman Pharmaceuticals & Chemicals: Updates

We are pleased to inform to the Investors that the Company, Dishman Carbogen Amcis Limited, has received Listing and Trading Approval for 161394272 Equity Shares of Rs.2/- each of the Company through Rule 19(2)(b) of Securities Contracts (Regulation) Rules, 1957 route for commencement of Trading of shares effective from Thursday, September 21, 2017 from both the Stock Exchanges i.e. BSE Limited and National Stock Exchange of India Ltd. vide their letter No. DCS/AMAL/TP/SV/5437/2017-18 dated 19th September, 2017 and NSE/LIST/19858 dated 19th September, 2017 respectively.

Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.

Other Categories